Pipeline
Orphan diseases
GNR-097
Duchenne muscular dystrophy (INN: gene therapy)
GNR-104
Hypophosphatasia (INN: asfotase alfa](inn: asfotase alfa)
GNR-105
Morquio syndrome, Mucopolysaccharidosis type IV (INN: elosulfase alfa)
GNR-118
Morquio syndrome, Mucopolysaccharidosis type IV (INN: elosulfase alfa)
Autoimmune diseases
GNR-093
Multiple sclerosis (INN: natalizumab)
GNR-085
Multiple sclerosis (INN: ocrelizumab)
Oncology
GNR-107
Metastatic colorectal cancer (INN: panitumumab)
Allergology
GNR-127
Allergen immunotherapy